Latest Clinical & Research News
Specialty: Endocrinology
Nearly 71 million people globally are projected to be displaced from their homes due to disasters, conflicts and disease outbreaks by the end of 2019. Citizens of low- and middle-income countries (LMICs) are disproportionately victimized in humanitarian crises like these, with an average displacement duration of 27 years.
Endocrinology patients tend to have chronic illnesses that require lifelong care. Furthermore, many endocrine conditions evolve, so appropriate treatment approaches can change over time as well.
Illustration by Randal Mckenzie
Over the past decade, gastric bypass surgery has been proven to reverse not only obesity but also type 2 diabetes in patients with both conditions. However, most diabetic patients do not meet current surgery criteria. And of those who do, fewer than two percent actually proceed due to concerns about risks.
Hypertension has become a public health crisis in the United States and around the world. While most hypertension specialists come from the disciplines of nephrology, cardiology or internal medicine, Naomi D. L. Fisher, MD, believes endocrinologists should play a role, too.
A periprosthetic joint infection (PJI) after total joint arthroplasty (TJA) is often a devastating experience for a patient, involving a long treatment process that dramatically reduces a patient’s quality of life.
The Center for Oncoendocrinology at Brigham and Women’s Hospital was established to provide expert endocrine care for cancer patients during and after treatment. Endocrinologists at the Center, a program of Dana-Farber/Brigham and Women’s Cancer Center, can provide specialized knowledge of endocrine issues that may affect your cancer patient.
The Setting Targets Achieving Results Diabetes Mellitus (STAR-DM) Program at Brigham and Women’s Hospital (BWH) offers your high-risk diabetes patients an intensive management program to meet their clinical targets, such as achieving their A1C target or avoiding too-low blood glucose.
A new study led by researchers at Brigham and Women’s Hospital (BWH) has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes. Plasma levels of GCD59 were also associated with the probability of delivering a large-for-gestational-age newborn. These findings were published in Diabetes Care. Read More
Although delaying insulin therapy leads to worsening of diabetes, new research by Brigham and Women’s Hospital (BWH) has found that 30 percent of patients with type 2 diabetes don’t begin insulin, a medication used to lower the body’s blood sugar levels, when it’s initially recommended, with the average start time being two years later. These findings were published today in the journal, Diabetic Medicine. Read More